ArticleCurrent protocols2026
Enrichment and Characterization Protocol for Plant-Derived Nanovesicles from the Aquatic Plant Wolffia globosa.
Article in Current protocols, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Enrichment and Characterization Protocol for Plant-Derived Nanovesicles from the Aquatic Plant Wolffia globosa.Current protocols · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
This article presents a rigorous and reproducible protocol for the enrichment of plant-derived nanovesicles (PDNVs) from the aquatic plant Wolffia globosa using differential ultracentrifugation combined with sucrose density gradient enrichment. The protocol is specifically optimized to address the technical challenges associated with PDNV enrichment from extremely small aquatic plants that require whole-plant homogenization, a process that inherently increases contamination from intracellular organelles, soluble proteins, and chlorophyll. The workflow integrates gentle homogenization, sequential low- and medium-speed centrifugation, sterile filtration, and an initial ultracentrifugation step to obtain crude PDNVs, followed by density-based separation using a discontinuous sucrose gradient (8%-30% w/v). This combined size- and density-based strategy enables effective enrichment of PDNVs while substantially reducing non-vesicular contaminants. Quality control and characterization are performed in accordance with MISEV2023 recommendations using nanoparticle tracking analysis (NTA) and transmission electron microscopy (TEM). Gradient-enriched PDNVs exhibit a predominantly nanoscale, homogeneous particle population with a mean diameter of approximately 105.3 nm and a particle concentration on the order of 10
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.